Welcome to our dedicated page for Banco Bilbao SEC filings (Ticker: BBVA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Banco Bilbao Vizcaya Argentaria, S.A. files U.S. disclosures as a foreign private issuer, with Form 6-K reports documenting bank results, securities-market notices, capital actions, and governance matters. The filings include quarterly earnings materials, Spanish regulatory communications, board committee composition updates, and information related to ordinary-share buyback programs carried out for share-capital reduction.
BBVA filings also document capital-structure transactions, including senior non-preferred notes and contingent convertible perpetual preferred Tier 1 securities. Related exhibits cover pricing agreements, supplemental indentures, security certificates, legal opinions, tax matters, and incorporation by reference into shelf registration statements, alongside disclosures about solvency capital treatment, risk and compliance oversight, and shareholder-reporting matters.
Banco Bilbao Vizcaya Argentaria, S.A. (BBVA) is holding a presentation for analysts about its public tender offer for shares of Banco Sabadell, S.A., which has been approved by the Spanish securities regulator CNMV. The presentation is scheduled for 12:00 noon (Madrid time) and can be followed live through BBVA’s website.
BBVA states that a recording of the presentation will remain available on its website for at least one month. The notice is dated September 5, 2025 and is signed by BBVA’s Global Head of Strategy & M&A, Victoria del Castillo Marchese.
Banco Bilbao Vizcaya Argentaria, S.A. (BBVA) reports that the U.S. Securities and Exchange Commission has granted it regulatory relief related to its voluntary tender offer for the entire share capital of Banco de Sabadell, S.A..
The relief covers three time-related areas so BBVA can align U.S. and Spanish rules: when the U.S. prospectus comes into effect, how BBVA may waive the minimum acceptance condition under Royal Decree 1066/2007 on takeover bids, and how any dividend paid by Banco de Sabadell during the acceptance period can trigger an adjustment to the offer consideration.
BBVA notes that the SEC letter detailing this relief is publicly available on the SEC website.
Banco Bilbao Vizcaya Argentaria (BBVA) has adjusted the consideration in its voluntary tender offer for all shares of Banco de Sabadell. The change reflects Banco Sabadell’s interim dividend of €0.07 per share, with an ex-dividend date of August 27, 2025, in line with the previously announced offer mechanics.
After this adjustment, BBVA is offering one newly issued BBVA ordinary share and €0.70 in cash for every 5.5483 Banco Sabadell ordinary shares. The stated aim is to keep the economic terms of the offer equivalent despite dividend payments made by Banco Sabadell.
Banco Bilbao Vizcaya Argentaria, S.A. (BBVA) has announced an irrevocable decision to redeem in full its $1,000,000,000 5.862% Senior Non-Preferred Fixed-to-Fixed Rate Notes due 2026 on 14 September 2025, which is the Notes' Reset Date. The aggregate redemption price is $1,029,130,000, equal to 100% of principal plus accrued but unpaid interest to, but excluding, the Redemption Date. Because 14 September 2025 is not a Business Day, the Redemption Price will be paid on the next Business Day, 15 September 2025, and no interest will accrue after the Redemption Date. Payment will be made upon surrender to The Bank of New York Mellon, London Branch, and DTC-held Notes must follow DTC procedures. BBVA obtained prior consent from the Single Resolution Board.
Capital Research Global Investors reported beneficial ownership of 181,099,527 shares of Banco Bilbao Vizcaya Argentaria (BBVA), representing 3.1% of the 5,763,285,465 shares the filer believes to be outstanding. The filing shows sole voting power over 180,746,617 shares and sole dispositive power over 181,099,527 shares. The reported holdings include 353,005 Depository Receipts that represent common stock. The filing identifies CRGI as a division of Capital Research and Management Company and related investment management affiliates, and it certifies the securities were acquired and are held in the ordinary course of business and not for the purpose of changing control.
Banco Bilbao Vizcaya Argentaria (BBVA) confirms it will maintain its voluntary tender offer for all shares of Banco de Sabadell despite recent actions by Sabadell. On August 6, 2025, Sabadell shareholders approved the sale of all shares and certain securities of its UK subsidiary TSB Banking Group plc to Banco Santander, subject to conditions precedent.
Sabadell’s meeting also approved an extraordinary cash dividend of €0.50 per share, to be paid from freely distributable voluntary reserves once the TSB sale is completed. Under Article 33.1(d) of Royal Decree 1066/2007, these resolutions entitled BBVA to withdraw its offer, with prior CNMV approval. After reviewing the resolutions and available information, BBVA chose not to withdraw, so the tender offer remains in effect under applicable regulations.
BANCO BILBAO VIZCAYA ARGENTARIA, S.A. filed a Form 13F reporting institutional holdings. The report lists 691 information-table entries with a total market value of $11,030,917,106 and names 11 other included managers. The filing is signed by Maria Angeles Pelaez Moron, Chief Accounting Officer.
BBVA filed a Form 6-K disclosing results of the 2025 EU-wide EBA stress test covering 2025-2027. The exercise, used for the 2025 Supervisory Review and Evaluation Process, applies a static 31-Dec-24 balance sheet and has no pass/fail threshold.
Baseline scenario: the bank’s fully-loaded CET1 ratio would rise 3.55 pp to 16.43 % by 31-Dec-27.
Adverse scenario: CET1 would fall 2.18 pp to a trough of 10.70 % in 2025, then recover to 11.02 % by 2027, remaining in double-digit territory throughout. No management actions or post-2024 business changes are reflected.
Results indicate BBVA can absorb a severe macro-financial shock while maintaining capital well above typical regulatory minima, supporting dividend capacity and funding flexibility. Investors should watch the forthcoming SREP decision and any updates to capital distribution policy.
BBVA delivered another strong set of results in 2Q25 despite a softer rate backdrop. Net attributable profit reached €2.75 bn, up 18 % YoY at constant FX, driving 6M25 profit to €5.45 bn (+31 %). ROTE climbed to 20.4 % and EPS was €0.46. Core income continued to expand: net interest income rose 11 % YoY (cc) to €6.21 bn and fees grew 18 % to €1.95 bn, more than offsetting a 49 % drop in trading income. Operating jaws remained positive and the cost-to-income ratio improved to 37.6 % (6M).
Asset quality was contained: the NPL ratio stayed at 2.9 % with coverage of 75 %; cost of risk held at 1.32 % YtD. Capital generation was robust—CET1 FL increased 25 bp in the quarter to 13.34 %, comfortably above the 11.5-12 % target range and the 9.12 % SREP requirement. Total loan book grew 11.2 % YoY (cc), led by Spain (+16 %) and Mexico (+12.6 %). Management raised medium-term guidance: group loans now seen growing above mid-single digits, efficiency ratio <40 %, and CET1 surplus of ~€36 bn available for distribution through 2028. The bank expects around €13 bn excess capital to be distributed in the short term, subject to approvals.